Eliahu Golomb
- Cardiology and Cardiovascular Medicine top 5%
- Molecular Biology
- Physiology top 10%
- Cell Biology top 10%
- Endocrinology, Diabetes and Metabolism top 10%
- Co-authors
- Zaid AbassiH R KeiserA. AbramoviciHarry R. KeiserJames E. TateRobert AdelsteinSachiyo KawamotoJames R. Sellers
- Topics
- Peptidase Inhibition and Analysis (6 papers)Breast Cancer Treatment Studies (5 papers)Breast Lesions and Carcinomas (5 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryJournal of Clinical Oncology
- Partner nations
- IsraelUnited StatesSwitzerland
In The Last Decade
Eliahu Golomb
46 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 110
- Cardiology and Cardiovascular Medicine 445
- Molecular Biology 433
- Physiology 244
- Cell Biology 182
- Endocrinology, Diabetes and Metabolism 181
Countries citing papers authored by Eliahu Golomb
This map shows the geographic impact of Eliahu Golomb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eliahu Golomb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eliahu Golomb more than expected).
Fields of papers citing papers by Eliahu Golomb
This network shows the impact of papers produced by Eliahu Golomb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eliahu Golomb. The network helps show where Eliahu Golomb may publish in the future.
Co-authorship network of co-authors of Eliahu Golomb
This figure shows the co-authorship network connecting the top 25 collaborators of Eliahu Golomb. A scholar is included among the top collaborators of Eliahu Golomb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eliahu Golomb. Eliahu Golomb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 13 | |
| 3 | 13 | |
| 4 | 4 | |
| 5 | 5 | |
| 6 | 67 | |
| 7 | 15 | |
| 8 | 267 | |
| 9 | 24 | |
| 10 | 41 | |
| 11 | 21 | |
| 12 | 55 | |
| 13 | 5 | |
| 14 | 37 | |
| 15 | 16 | |
| 16 | 40 | |
| 17 | 35 | |
| 18 | 4 | |
| 19 | 35 | |
| 20 | 43 |
About Eliahu Golomb
Eliahu Golomb is a scholar working on Urology, Cardiology and Cardiovascular Medicine and Aging, having authored 47 papers that have together received 1.4k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (6 papers), Breast Cancer Treatment Studies (5 papers) and Breast Lesions and Carcinomas (5 papers). The work is most often cited by research in Urology (151 citations), Cardiology and Cardiovascular Medicine (445 citations) and Biochemistry (98 citations). Eliahu Golomb has collaborated with scholars based in Israel, United States and Switzerland. Frequent co-authors include Zaid Abassi, H R Keiser, A. Abramovici, Harry R. Keiser, James E. Tate, Robert Adelstein, Sachiyo Kawamoto, James R. Sellers, Xuefei Ma and Mary Anne Conti. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.